Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

134.91 +0.81 (+0.60%)

Streaming Delayed Price Updated: 3:17 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

3 of Wall Street’s Favorite Stocks That Concern Us

January 01, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare

December 24, 2025

The convergence of consumer technology and clinical medicine has reached a fever pitch as 2025 draws to a close. A landmark report released this December by ResearchAndMarkets.com projects that the...

Via MarketMinute

Topics Artificial Intelligence

1 Healthcare Stock to Research Further and 2 That Underwhelm

December 15, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Masimo Earnings Preview ↗

November 03, 2025

Via Benzinga

How Is The Market Feeling About Masimo? ↗

September 05, 2025

Via Benzinga

Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)

December 07, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Masimo (NASDAQ:MASI) and the best and worst...

Via StockStory

Topics Artificial Intelligence

Masimo (MASI) Stock Is Up, What You Need To Know

December 05, 2025

Shares of medical tech company Masimo (NASDAQ:MASI) jumped 3.5% in the morning session after the company presented an upbeat long-term financial outlook at its 2025 Investor Day, prompting positive...

Via StockStory

Topics Artificial Intelligence Economy Supply Chain

Masimo (MASI) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Masimo (MASI) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

1 Volatile Stock to Target This Week and 2 We Ignore

November 25, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

2 Small-Cap Stocks to Target This Week and 1 That Underwhelm

November 17, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 17, 2025

Via Benzinga

Apple Ordered To Pay $634 Million After Jury Finds Company Infringed Masimo's Blood-Oxygen Sensor Patent ↗

November 17, 2025

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology.

Via Benzinga

Topics Intellectual Property

4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares ↗

November 16, 2025

4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares

Via The Motley Fool

5 Insightful Analyst Questions From Masimo’s Q3 Earnings Call

November 11, 2025

Masimo’s third quarter results for 2025 were met with a significant negative market reaction, despite the company surpassing Wall Street’s revenue and adjusted profit expectations. Management...

Via StockStory

Topics Earnings

MASI Q3 Deep Dive: Margin Expansion and Product Pipeline Shape Outlook

November 05, 2025

Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.2% year on year to $371.5 million. The company expects the full year’s...

Via StockStory

Masimo’s (NASDAQ:MASI) Q3 Sales Top Estimates

November 04, 2025

Medical tech company Masimo (NASDAQ:MASI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.2% year on year to $371.5 million. The company expects the full year’s...

Via StockStory

Earnings To Watch: Masimo (MASI) Reports Q3 Results Tomorrow

November 02, 2025

Medical tech company Masimo (NASDAQ:MASI) will be reporting results this Tuesday after market hours. Here’s what you need to know.

Via StockStory

1 Unprofitable Stock with Exciting Potential and 2 We Brush Off

October 31, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Topics Electric Vehicles

$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today ↗

October 24, 2025

Via Benzinga

Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock ↗

October 17, 2025

Via Benzinga

DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

October 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

3 Healthcare Stocks We Think Twice About

October 03, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Via StockStory

Topics Stocks

3 Reasons MASI is Risky and 1 Stock to Buy Instead

October 02, 2025

Over the past six months, Masimo’s shares (currently trading at $142) have posted a disappointing 17.2% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next...

Via StockStory

Topics Stocks

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today ↗

September 29, 2025

Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average annual return of 13.99%. Currently, Masimo has a market capitalization of...

Via Benzinga

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

September 02, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.